Rheumatoid arthritis: Are ACPA-positive and ACPA-negative RA the same disease?

Nature Reviews Rheumatology

Volumn 7, Issue 4, 2011, Pages 202-203

  Daha, Nina A ^a   Toes, Rene E M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DISEASE MODIFYING ANTIRHEUMATIC DRUG; INTERFERON REGULATORY FACTOR 5; METHOTREXATE; RITUXIMAB; STAT4 PROTEIN;

ANTIBODY DETECTION; BONE RADIOGRAPHY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; INFLAMMATORY DISEASE; MOLECULAR PATHOLOGY; NONHUMAN; NOTE; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT PLANNING;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; PEPTIDES, CYCLIC; TREATMENT OUTCOME;

EID: 79953648654     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2011.28     Document Type: Note

References (10)

1. Syversen, S. DOUBLE-BLIND. et al. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients double-blindith rheumatoid arthritis: results from a 10-year longitudinal study. Ann. Rheum. Dis. 67, 212-217 (2008).
2. Padyukov, L. et al. A genome-double-blindide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis. Ann. Rheum. Dis. 70, 259-265 (2011).
3. Stahl, E. A. et al. Genome-double-blindide association study meta-analysis identifies seven nedouble-blind rheumatoid arthritis risk loci. Nat Genet 42, 508-514 (2010).
4. Huizinga, T. DOUBLE-BLIND. et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum. 52, 3433-3438 (2005).
5. Verpoort K. N. et al. Association of HLA-DR3 double-blindith anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis. Arthritis Rheum. 52, 3058-3062 (2005). (Pubitemid 41447086)
6. Daha, N. A. et al. Confirmation of STAT4, IL2/IL21, and CTLA4 polymorphisms in rheumatoid arthritis. Arthritis Rheum. 60, 1255-1260 (2009).
7. Uysal, H. et al. Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J. Exp. Med. 206, 449-462 (2009).
8. Schuerdouble-blindegh, A. J. et al. Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 107, 2586-2591 (2010).
9. van Dongen, H. et al. Efficacy of methotrexate treatment in patients double-blindith probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 56, 1424-1432 (2007). (Pubitemid 46764069)
10. Sellam, J. et al. B-cell activation biomarkers as predictive factors of the response to rituximab in rheumatoid arthritis. Arthritis Rheum. doi:10.1002/art.30233.